Enochian Biosciences is a pre-clinical stage biotech company that develops and researches pharmaceutical and biological products for human treatment with different viruses and cancer. The company's lead candidate is the ENOB-HV-01, which aims to cure autologous HIV; ENOB-HV-11, is a preventative HIV vaccine and ENOB-HV-12 is a therapeutic HIV vaccine. Enochian Biosciences has formed alliances with various institutions that include The Scripps Institute, the Hepatitis B Foundation and Baruch S. Blumberg Institute, Fred Hutchinson Cancer Research Center, Texas Biomedical Research Institute, and the University of California, Los Angeles.